T. Frisan et al., Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells, INT J CANC, 88(6), 2000, pp. 881-888
We investigated the expression of interferon gamma (IFN-gamma)-regulated su
bunits and the enzymatic activity of proteasomes purified from tumor derive
d and normal B lymphocytes representing different stages of B-cell activati
on/ differentiation. The catalytic beta subunits (Lmp2 and Lmp7) and the re
gulatory subunits (PA28 alpha and PA28 beta) were expressed at equally high
levels in Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (
LCLs), freshly isolated B-chronic lymphocytic leukemia (B-CLL) cells and no
rmal CD23(-) B lymphocytes. Lmp2 and Lmp7 were selectively down-regulated i
n germinal center cell derived Burkitt's lymphoma (BL) and Hodgkin's lympho
ma (HD) cell lines. There was a direct correlation between the expression o
f Lmp2/7 and the chymotrypsin and trypsin-like activities in proteasomes pu
rified from LCLs, BLs and CLL cells, whereas 5 HD cell lines expressing B o
r T-cell markers exhibited a variable pattern of subunit expression and enz
ymatic activity, Poor hydrolysis of the fluorogenic substrates by proteasom
es from BL cells correlated with a distinct pattern of cleavage of a refere
nce 50mer peptide, production of different sets of degradation products and
significantly reduced recovery of a known cytotoxic T-lymphocyte (CTL) tar
get epitope, The enzymatic activity of proteasomes from normal CD23(-) "res
ting" B lymphocytes resembled that of BL cells in spite of high Lmp2/7 expr
ession, This pattern was not reversed by treatment with the B-cell mitogen,
lipopolysaccharide (LPS), The results suggest that different stages of B-c
ell activation/differentiation are associated with distinct profiles of IFN
-gamma -regulated subunit composition and enzymatic activity of the proteas
ome. This may have important implications for the analysis and manipulation
of tumor-specific immune responses. Int. J. Cancer 88:881-888, 2000. (C) 2
000 Wiley-Liss, Inc.